Mumbai : Unichem and PharmaSecure today announced that Unichem has purchased 70 million of PharmaSecure’s codes to be applied for use in protecting its brand and consumers against counterfeiting and diversion.

The unique identifier codes will be applied to several of Unichem’s leading medicines, including Trika for the treatment of anxiety and Losar for the treatment of high blood pressure and hypertension. The codes will be integrated into existing manufacturing processes at two plants in India.

This unique product security solution empowers consumers to check whether a drug is authentic via text message (SMS) using a mobile phone. When a consumer receives their medication, they are able to text the unique identifier on the individual strip to a phone number that is printed alongside the code. The consumer then receives an authentication text message from Unichem in response.

This is the only technology currently in use in the Indian market that empowers consumers themselves to check the authenticity of their medicines.

This system ensures data protection and brand security to manufacturers for branded, branded generic and generic manufacturers through seamless factory integration. It also provides customized CRM services based on its authentication platform to enhanced consumer protection and improved health outcomes.

Unichem chose PharmaSecure’s technology because of it’s high scalability and the team’s ability to integrate the system efficiently into its current factory processes. There will be no change to the Unichem’s manufacturing process and production output will remain the same.